| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.41 | 0.02 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.4 | 0.03 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |